This inventor holds 1 USPTO granted patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Valentina D'arienzo: Innovator in Oligonucleotide Technology
Introduction
Valentina D'arienzo is a prominent inventor based in Basel, Switzerland. She has made significant contributions to the field of biotechnology, particularly in the development of oligonucleotides. Her work focuses on advancing the understanding and modulation of gene expression.
Latest Patents
Valentina holds a patent titled "Enhanced Oligonucleotides for Modulating FUBP1 Expression." This innovative patent reflects her expertise in creating oligonucleotides that can effectively influence gene expression, which has important implications for therapeutic applications.
Career Highlights
Valentina is currently employed at Hoffmann-La Roche Inc., a leading global healthcare company. Her role at the company allows her to collaborate with other experts in the field and contribute to groundbreaking research and development projects.
Collaborations
One of her notable collaborators is Sabine Sewing, who is also a talented professional in the biotechnology sector. Together, they work on advancing research initiatives that aim to improve health outcomes through innovative solutions.
Conclusion
Valentina D'arienzo's contributions to biotechnology, particularly through her patent on oligonucleotides, highlight her role as a key innovator in the field. Her work at Hoffmann-La Roche Inc. and collaborations with other experts further emphasize her commitment to advancing scientific knowledge and technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile